HIGHLIGHTS
- who: Friedemann Schad and Anja Thronicke from the Network Oncology, Research Institute Havelhu00f6he, Kladower Damm, Berlin, Germany have published the article: Safety of Combined Targeted and Helixoru00ae Viscum album L. Therapy in Breast and Gynecological Cancer Patients, a Real-World Data Study, in the Journal: (JOURNAL)
- what: The aim of this real-world data study was to determine the safety profile of targeted therapy in combination with add-on Methods:
SUMMARY
Targeted therapy as the foundation for precision medicine consists of small_molecules or monoclonal_antibodies that aim to inhibit or induce proteins . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.